Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
l-glutamine (1 trial)
agalsidase alfa (Replagal) (2 trials)
Critical Illness (Phase 4)
Fabry Disease (Phase 3)
Trials (3 total)
Trial APIs (2 total)